Literature DB >> 18383339

Further evidence for a crucial role of resident endoneurial macrophages in peripheral nerve disorders: lessons from acrylamide-induced neuropathy.

Marcus Müller1, Karin Wacker, Daniel Getts, Erich Bernd Ringelstein, Reinhard Kiefer.   

Abstract

Endoneurial macrophages are crucially involved in the pathogenesis of neuropathies. Historically, the macrophage response in neuropathies is believed to be of hematogenous origin. However, recent studies could demonstrate an intrinsic generation of the early macrophage response by resident endoneurial macrophages after traumatic nerve injury and in a model of hereditary neuropathy. We hypothesized that the local macrophage response might suffice to generate an appropriate macrophage response in mild neuropathies, supplemented by infiltrating macrophages only in severe nerve pathology. To clarify this assumption, we investigated the macrophage response in acrylamide-induced neuropathy as a model of a slowly progressive neuropathy with a defined onset. We induced the neuropathy in bone marrow chimeric mice carrying green fluorescent protein transgenic bone marrow, allowing the differentiation of resident (GFP(-)) and invading hematogenous endoneurial (GFP(+)) macrophages. Quantification of GFP(-) and GFP(+) endoneurial macrophages in the sciatic nerve revealed an increase only of resident macrophages in proximal parts, whereas in distal parts a minor additional influx of hematogenous macrophages was observed. The immunohistochemical profile of GFP(-) and GFP(+) macrophages was similar but distal GFP(-) macrophages were differentially activated than their GFP(+) counterparts. Characterization of CCR2-deficient mice revealed a function for this chemokine system in attracting hematogenous macrophages but not in generating the intrinsic macrophage response. In conclusion, we provide evidence for a role of resident macrophages in acrylamide-induced neuropathy. Resident endoneurial macrophages intrinsically generate the macrophage response in this slowly progressive neuropathy, which only becomes supplemented by hematogenous macrophages in distal areas of more pronounced damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18383339     DOI: 10.1002/glia.20674

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  6 in total

1.  CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.

Authors:  Marius Krauthausen; Markus P Kummer; Julian Zimmermann; Elisabet Reyes-Irisarri; Dick Terwel; Bruno Bulic; Michael T Heneka; Marcus Müller
Journal:  J Clin Invest       Date:  2014-12-15       Impact factor: 14.808

2.  Resident Macrophages in Muscle Contribute to Development of Hyperalgesia in a Mouse Model of Noninflammatory Muscle Pain.

Authors:  Wei-Yi Gong; Ramy E Abdelhamid; Carolina S Carvalho; Kathleen A Sluka
Journal:  J Pain       Date:  2016-07-01       Impact factor: 5.820

3.  P2X4 Receptors on Muscle Macrophages Are Required for Development of Hyperalgesia in an Animal Model of Activity-Induced Muscle Pain.

Authors:  Maria Claudia Oliveira-Fusaro; Nicholas S Gregory; Sandra J Kolker; Lynn Rasmussen; Lee-Ann H Allen; Kathleen A Sluka
Journal:  Mol Neurobiol       Date:  2020-01-02       Impact factor: 5.590

4.  Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain.

Authors:  Hosung Jung; Sonia Bhangoo; Ghazal Banisadr; Caroline Freitag; Dongjun Ren; Fletcher A White; Richard J Miller
Journal:  J Neurosci       Date:  2009-06-24       Impact factor: 6.167

5.  STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.

Authors:  Jonathan S Fletcher; Mitchell G Springer; Kwangmin Choi; Edwin Jousma; Tilat A Rizvi; Eva Dombi; Mi-Ok Kim; Jianqiang Wu; Nancy Ratner
Journal:  Oncogene       Date:  2018-12-12       Impact factor: 9.867

6.  Unilateral Sciatic Nerve Crush Induces White Blood Cell Infiltration of the Contralateral Nerve.

Authors:  Jia Cheng; Lingtao Ding; Minlie Yang; Yugang Zhu; Zaiqiu Gu; Guozhong Lv
Journal:  J Healthc Eng       Date:  2022-03-29       Impact factor: 2.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.